دورية أكاديمية

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

التفاصيل البيبلوغرافية
العنوان: Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma
المؤلفون: Powles, Thomas, Assaf, Zoe June, Degaonkar, Viraj, Grivas, Petros, Hussain, Maha, Oudard, Stephane, Gschwend, Jürgen E., Albers, Peter, Castellano, Daniel, Nishiyama, Hiroyuki, Daneshmand, Siamak, Sharma, Shruti, Sethi, Himanshu, Aleshin, Alexey, Shi, Yi, Davarpanah, Nicole, Carter, Corey, Bellmunt, Joaquim, Mariathasan, Sanjeev
المصدر: European Urology ; volume 85, issue 2, page 114-122 ; ISSN 0302-2838
بيانات النشر: Elsevier BV
سنة النشر: 2024
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.eururo.2023.06.007
الإتاحة: https://doi.org/10.1016/j.eururo.2023.06.007Test
https://api.elsevier.com/content/article/PII:S0302283823029020?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0302283823029020?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.3FFE43C7
قاعدة البيانات: BASE